Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review

Study Overview
=================
Brief Summary
-----------------
To evaluate the clinical outcomes of AcrySof® ReSTOR® IOL for the Faculty Practice at UTSW Medical Center at Dallas

Detailed Description
-----------------
The AcrySof® ReSTOR® intraocular lens (IOL) is the latest advance in vision surgery. This IOL has been uniquely designed to improve vision throughout the entire visual spectrum, up close, far away and everything in-between. Thus, giving cataract patients their best chance ever to function free of glasses. The pre-operative and post-operative data from ReSTOR® IOL implant cataract surgeries will be analyzed to determine whether the desired outcome was achieved, i.e. excellent vision with no correction. Variables to be studied include patient age, gender, number of ReSTOR® IOL implants, ocular comorbidities, preoperative and postoperative corrected and uncorrected visual acuities, keratometry readings, and corneal topography readings. A patient survey will also be sent to patients having undergone the surgery to measure their level of satisfaction. Project Goals: The ultimate outcome of this project is to learn more insight on the following: Visual acuity with and without correction of distance and near at 3-6 months Percent of patients requiring keratorefractive surgery Ocular comorbidity subgroup analysis Monocular implantation subanalysis (prior to LASIK) Comparison of post-op spherical equivalent to target refraction Posterior capsule opacity that may be treated with laser procedure known as a YAG laser capsulotomy? Subjective patient satisfaction Validated questionnaire assessing visual function and quality of life

Official Title
-----------------
Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review

Conditions
-----------------
Outcomes Following Restor IOL Lens Implant

Intervention / Treatment
-----------------
* Device: Restor IOL


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All patients of any race and sex between the ages of 18-90 years of age who have undergone ReSTOR® IOL cataract surgery will be recruited in this retrospective project. Exclusion Criteria: Patients who underwent conventional IOL cataract extraction surgery

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Device: Restor IOL|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| 1)Visual acuity with and without correction of distance and near at 3-6 months |  |  | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percent of patients requiring keratorefractive surgery |  |  | 
| Ocular comorbidity subgroup analysis |  |  | 
| Monocular implantation subanalysis (prior to LASIK) |  |  | 
| Comparison of post-op spherical equivalent to target refraction |  |  | 
| Posterior capsule opacity that may be treated with laser procedure known as a YAG laser capsulotomy? |  |  | 
| Subjective patient satisfaction |  |  | 
| Validated questionnaire assessing visual function and quality of life |  |  | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Higher Order Abberations